{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T16:18:16Z","timestamp":1770481096077,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,27]],"date-time":"2012-08-27T00:00:00Z","timestamp":1346025600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Harpalycin 2 (HP-2) is an isoflavone isolated from the leaves of <jats:italic>Harpalyce brasiliana<\/jats:italic> Benth., a snakeroot found in northeast region of Brazil and used in folk medicine to treat snakebite. Its leaves are said to be anti-inflammatory. Secretory phospholipases A<jats:sub>2<\/jats:sub> are important toxins found in snake venom and are structurally related to those found in inflammatory conditions in mammals, as in arthritis and atherosclerosis, and for this reason can be valuable tools for searching new anti-phospholipase A<jats:sub>2<\/jats:sub> drugs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>HP-2 and piratoxin-III (PrTX-III) were purified through chromatographic techniques. The effect of HP-2 in the enzymatic activity of PrTX-III was carried out using 4-nitro-3-octanoyloxy-benzoic acid as the substrate. PrTX-III induced platelet aggregation was inhibited by HP-2 when compared to aristolochic acid and p-bromophenacyl bromide (p-BPB). In an attempt to elucidate how HP-2 interacts with PrTX-III, mass spectrometry, circular dichroism and intrinsic fluorescence analysis were performed. Docking scores of the ligands (HP-2, aristolochic acid and p-BPB) using PrTX-III as target were also calculated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>HP-2 inhibited the enzymatic activity of PrTX-III (IC<jats:sub>50<\/jats:sub> 11.34\u2009\u00b1\u20090.28\u2009\u03bcg\/mL) although it did not form a stable chemical complex in the active site, since mass spectrometry measurements showed no difference between native (13,837.34\u2009Da) and HP-2 treated PrTX-III (13,856.12\u2009Da). A structural analysis of PrTX-III after treatment with HP-2 showed a decrease in dimerization and a slight protein unfolding. In the platelet aggregation assay, HP-2 previously incubated with PrTX-III inhibited the aggregation when compared with untreated protein. PrTX-III chemical treated with aristolochic acid and p-BPB, two standard PLA<jats:sub>2<\/jats:sub> inhibitors, showed low inhibitory effects when compared with the HP-2 treatment. Docking scores corroborated these results, showing higher affinity of HP-2 for the PrTX-III target (PDB code: 1GMZ) than aristolochic acid and p-BPB. HP-2 previous incubated with the platelets inhibits the aggregation induced by untreated PrTX-III as well as arachidonic acid.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>HP-2 changes the structure of PrTX-III, inhibiting the enzymatic activity of this enzyme. In addition, PrTX-III platelet aggregant activity was inhibited by treatment with HP-2, p-BPB and aristolochic acid, and these results were corroborated by docking scores.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1472-6882-12-139","type":"journal-article","created":{"date-parts":[[2012,8,27]],"date-time":"2012-08-27T20:13:58Z","timestamp":1346098438000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Harpalycin 2 inhibits the enzymatic and platelet aggregation activities of PrTX-III, a D49 phospholipase A2 from Bothrops pirajai venom"],"prefix":"10.1186","volume":"12","author":[{"given":"Rafael M","family":"Ximenes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata S","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ticiana P","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata M","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edilberto R","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo M","family":"Rabello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo Z","family":"Hernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica C G","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Bristot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila L","family":"Pires","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela O","family":"Toyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrique H","family":"Gaeta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena S A","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos H","family":"Toyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,27]]},"reference":[{"key":"1161_CR1","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.jep.2004.12.013","volume":"97","author":"P Pithayanukul","year":"2007","unstructured":"Pithayanukul P, Ruenraroengsak P, Bavovada R, Pakmanee N, Suttisri R, Saen-oon S: Inhibition of Naja kaouthia venom activities by plants polyphenols. J Ethnopharmacol. 2007, 97: 527-533.","journal-title":"J Ethnopharmacol"},{"key":"1161_CR2","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.1016\/S0040-4039(00)87726-6","volume":"23","author":"M Nakagawa","year":"1982","unstructured":"Nakagawa M, Nakanishi K, Darko LL, Vick JA: Structures of cabenegrins A-I and A-II, potent anti-snake venoms. Tetrahedron Lett. 1982, 23: 3855-3858. 10.1016\/S0040-4039(00)87726-6.","journal-title":"Tetrahedron Lett"},{"key":"1161_CR3","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1590\/S0103-50531999000600003","volume":"10","author":"GL Silva","year":"1999","unstructured":"Silva GL, Machado MIL, Matos FJA, Braz-Filho R, Silveira ER: A new isoflavone isolated from Harpalyce brasiliana. J Braz Chem Soc. 1999, 10: 438-442. 10.1590\/S0103-50531999000600003.","journal-title":"J Braz Chem Soc"},{"key":"1161_CR4","volume-title":"Avalia\u00e7\u00e3o da atividade da cabenegrina A-II frente \u00e0s altera\u00e7\u00f5es bioqu\u00edmicas e hematol\u00f3gicas e aos efeitos press\u00f3ricos induzidos pelo veneno de Bothrops jararacussu em ratos","author":"RM Ximenes","year":"2009","unstructured":"Ximenes RM: Avalia\u00e7\u00e3o da atividade da cabenegrina A-II frente \u00e0s altera\u00e7\u00f5es bioqu\u00edmicas e hematol\u00f3gicas e aos efeitos press\u00f3ricos induzidos pelo veneno de Bothrops jararacussu em ratos. 2009, Disserta\u00e7\u00e3o de Mestrado. Universidade Federal do Cear\u00e1, Departamento de Fisiologia e Farmacologia"},{"key":"1161_CR5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1023\/A:1027306118026","volume":"21","author":"M Lindahl","year":"1997","unstructured":"Lindahl M, Tagesson C: Flavonoids as phospholipase A2 inhibitors: importance of their structure for selective inhibition of group II phospholipase A2. Inflammation. 1997, 21: 347-453. 10.1023\/A:1027306118026.","journal-title":"Inflammation"},{"key":"1161_CR6","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S1043-6618(03)00225-1","volume":"48","author":"AE Rotelli","year":"2003","unstructured":"Rotelli AE, Guardia T, Juarez AO, de la Rocha NE, Pelzer LE: Comparative study of flavonoids in experimental models of inflammation. Pharmacol Res. 2003, 48: 601-606. 10.1016\/S1043-6618(03)00225-1.","journal-title":"Pharmacol Res"},{"key":"1161_CR7","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.toxicon.2005.07.017","volume":"46","author":"CV Iglesias","year":"2005","unstructured":"Iglesias CV, Aparicio R, Rodrigues-Simioni L, Camargo EA, Antunes E, Marangoni S, Toyama DO, Beriam LO, Monteiro HS, Toyama MH: Effects of morin on snake venom phospholipase A2 (PLA2). Toxicon. 2005, 46: 751-758. 10.1016\/j.toxicon.2005.07.017.","journal-title":"Toxicon"},{"key":"1161_CR8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.toxicon.2008.12.018","volume":"53","author":"DO Toyama","year":"2009","unstructured":"Toyama DO, Marangoni S, Diz-Filho EBS, Oliveira SCB, Toyama MH: Effect of Umbelliferone (7-hydroxycoumarin, 7-HOC) on the enzymatic, edematogenic and necrotic activities of secretory phospholipase A2 (sPLA2) isolated from Crotalus durissus collilineatus venom. Toxicon. 2009, 53: 417-426. 10.1016\/j.toxicon.2008.12.018.","journal-title":"Toxicon"},{"key":"1161_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0006-2952(97)00215-3","volume":"55","author":"G Cirino","year":"1985","unstructured":"Cirino G: Multiple control in inflammation. Extracellular and intracellular phospholipase A2, inducible and constitutive cyclooxgenase and inducible nitric oxide synthase. Biochem Pharmacol. 1985, 55: 105-111.","journal-title":"Biochem Pharmacol"},{"key":"1161_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0014-5793(02)03401-4","volume":"531","author":"L Fuentes","year":"2002","unstructured":"Fuentes L, Hernandez M, Nieto ML, Crespo MS: Biological effects of group IIA secreted phospholipase A2. FEBS Lett. 2002, 531: 7-11. 10.1016\/S0014-5793(02)03401-4.","journal-title":"FEBS Lett"},{"key":"1161_CR11","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S0006-2952(96)00773-3","volume":"53","author":"B Gil","year":"1997","unstructured":"Gil B, Sanz MJ, Terencio MC, Gunasegaran R, Pay\u00e1 M, Alcaraz MJ: Morelloflavone, a novel biflavonoid inhibitor of human secretory phospholipase A2 with anti-inflammatory activity. Biochem Pharmacol. 1997, 53: 733-740. 10.1016\/S0006-2952(96)00773-3.","journal-title":"Biochem Pharmacol"},{"key":"1161_CR12","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0041-0101(03)00085-0","volume":"41","author":"MH Toyama","year":"2003","unstructured":"Toyama MH, de Oliveira DG, Beriam LO, Novello JC, Rodrigues-Simioni L, Marangoni S: Structural, enzymatic and biological properties of new PLA(2) isoform from Crotalus durissus terrificus venom. Toxicon. 2003, 41: 1033-1038. 10.1016\/S0041-0101(03)00085-0.","journal-title":"Toxicon"},{"key":"1161_CR13","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1107\/S0907444999004576","volume":"55","author":"WH Lee","year":"1999","unstructured":"Lee WH, Toyama MH, Soares AM, Giglio JR, Marangoni S, Polikarpov I: Crystallization and preliminary X-ray diffraction studies of piratoxin III, a D-49 phospholipase A(2) from the venom of Bothrops pirajai. Acta Crystallogr D: Biol Crystallogr. 1999, 55: 1229-1230. 10.1107\/S0907444999004576.","journal-title":"Acta Crystallogr D: Biol Crystallogr"},{"key":"1161_CR14","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1006\/abbi.2000.2244","volume":"387","author":"AM Soares","year":"2001","unstructured":"Soares AM, Andri\u00e3o-Escarso SH, Bortoleto RK, Rodrigues-Simoni L, Arni RK, Ward RJ, Guti\u00e9rrez JM, Giglio JR: Dissociation of Enzymatic and Pharmacological Properties of Piratoxins-I and \u2013III, two myotoxic phospholipases A2 from Bothrops pirajai sanke venom. Arc Biochem Biophys. 2001, 387: 188-196. 10.1006\/abbi.2000.2244.","journal-title":"Arc Biochem Biophys"},{"key":"1161_CR15","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1023\/A:1021051831740","volume":"18","author":"MH Toyama","year":"1999","unstructured":"Toyama MH, Costa PD, Novello JC, de Oliveira B, Giglio JR, da Cruz-H\u00f6fling MA, Marangoni S: Purification and amino acid sequence of MP-III 4R D-49 phospholipase A2 from Bothrops pirajai snake venom, a toxin with moderate PLA2 and anticoagulant activities and high myotoxic activity. J Protein Chem. 1999, 18: 371-378. 10.1023\/A:1021051831740.","journal-title":"J Protein Chem"},{"key":"1161_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10930-004-1517-5","volume":"24","author":"MH Toyama","year":"2005","unstructured":"Toyama MH, Toyama DO, Joazeiro PP, Carneiro EM, Beriam LO, Marangoni S, Boschero AC: Biological and structural characterization of a new PLA2 from the Crotalus durissus collilineatus venom. Protein J. 2005, 24: 103-112. 10.1007\/s10930-004-1517-5.","journal-title":"Protein J"},{"key":"1161_CR17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1023\/A:1015320616206","volume":"21","author":"DG Oliveira","year":"2002","unstructured":"Oliveira DG, Toyama MH, Novello JC, Beriam LO, Marangoni S: Structural and functional characterization of basic PLA2 isolated from Crotalus durissus terrificus venom. J Protein Chem. 2002, 21: 161-168. 10.1023\/A:1015320616206.","journal-title":"J Protein Chem"},{"key":"1161_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1471-2091-9-16","volume":"9","author":"SC Oliveira","year":"2008","unstructured":"Oliveira SC, Fonseca FV, Antunes E, Camargo EA, Morganti RP, Apar\u00edcio R, Toyama DO, Beriam LO, Nunes EV, Cavada BS, Nagano CS, Sampaio AH, Nascimento KS, Toyama MH: Modulation of the pharmacological effects of enzymatically-active PLA2 by BTL-2, an isolectin isolated from the Bryothamnion triquetrum red alga. BMC Biochem. 2008, 9: 16-10.1186\/1471-2091-9-16.","journal-title":"BMC Biochem"},{"key":"1161_CR19","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3390\/ijms9050736","volume":"9","author":"ML dos Santos","year":"2008","unstructured":"dos Santos ML, Fagundes FH, Teixeira BR, Toyama MH, Aparicio R: Purification and Preliminary Crystallographic Analysis of a New Lys49-PLA2 from B Jararacussu. Int J Mol Sci. 2008, 9: 736-750. 10.3390\/ijms9050736.","journal-title":"Int J Mol Sci"},{"key":"1161_CR20","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1021\/ja00299a024","volume":"107","author":"MJS Dewar","year":"1985","unstructured":"Dewar MJS, Zoebisch EG, Healy EF, Stewart JJP: Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model. J Am Chem Soc. 1985, 107: 3902-3909. 10.1021\/ja00299a024.","journal-title":"J Am Chem Soc"},{"key":"1161_CR21","unstructured":"BioMedCache version 6.1, Copyright\u00a9. 2000, Oxford Molecular Ltd, http:\/\/\/www.CACheSoftware.com., \u20132003 Fujitsu Limited, Copyright\u00a9 1989\u20132000"},{"key":"1161_CR22","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","volume":"267","author":"G Jones","year":"1997","unstructured":"Jones G, Willett P, Glen RC, Leach AR, Taylor R: Development and Validation of a Genetic Algorithm for Flexible Docking. J Mol Biol. 1997, 267: 727-748. 10.1006\/jmbi.1996.0897.","journal-title":"J Mol Biol"},{"key":"1161_CR23","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.toxicon.2003.11.008","volume":"42","author":"B Lomonte","year":"2003","unstructured":"Lomonte B, Angulo Y, Calder\u00f3n L: An overview of lysine-49 phospholipase A2 myotoxins from crotalid snake venoms and their structural determinants of myotoxic action. Toxicon. 2003, 42: 885-901. 10.1016\/j.toxicon.2003.11.008.","journal-title":"Toxicon"},{"key":"1161_CR24","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.toxicon.2003.11.027","volume":"42","author":"L Chioato","year":"2003","unstructured":"Chioato L, Ward RJ: Mapping structural determinants of biological activities in snake venom phospholipases A2 by sequence analysis and site directed mutagenesis. Toxicon. 2003, 42: 869-883. 10.1016\/j.toxicon.2003.11.027.","journal-title":"Toxicon"},{"key":"1161_CR25","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.bbalip.2006.08.003","volume":"1761","author":"S Yedgar","year":"2006","unstructured":"Yedgar S, Cohen Y, Shoseyov D: Control of phospholipase A2 activities for the treatment of inflammatory conditions. Biochim Biophys Acta. 2006, 1761: 1373-1382. 10.1016\/j.bbalip.2006.08.003.","journal-title":"Biochim Biophys Acta"},{"key":"1161_CR26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1023\/A:1010956126585","volume":"20","author":"VL Bonfim","year":"2001","unstructured":"Bonfim VL, Toyama MH, Novello JC, Hyslop S, Oliveira CR, Rodrigues-Simioni L, Marangoni S: Isolation and enzymatic characterization of a basic phospholipase A2 from Bothrops jararacussu snake venom. J Protein Chem. 2001, 20: 239-234. 10.1023\/A:1010956126585.","journal-title":"J Protein Chem"},{"key":"1161_CR27","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1021\/cr990139w","volume":"101","author":"OG Berg","year":"2001","unstructured":"Berg OG, Gelb MH, Tsai MD, Jain MK: Interfacial enzymology: the secreted phospholipase A2-paradigm. Chem Rev. 2001, 101: 2613-2653. 10.1021\/cr990139w.","journal-title":"Chem Rev"},{"key":"1161_CR28","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1042\/bj3270259","volume":"327","author":"J Polg\u00e1r","year":"1997","unstructured":"Polg\u00e1r J, Kramer RM, Um SL, Jakubowski JA, Clemetson KJ: Human group II 14\u2009kDa phospholipase A2 activates human platelets. Biochem J. 1997, 327: 259-265.","journal-title":"Biochem J"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6882-12-139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6882-12-139\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6882-12-139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T20:57:25Z","timestamp":1630529845000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/1472-6882-12-139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,27]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1161"],"URL":"https:\/\/doi.org\/10.1186\/1472-6882-12-139","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,27]]},"assertion":[{"value":"16 April 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"139"}}